Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

OBIO Insider Trading

Orchestra BioMed Holdings, Inc. | Surgical & Medical Instruments & Apparatus

Comprehensive Trading Performance Summary

The investment history of corporate insiders at Orchestra BioMed Holdings, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Surgical & Medical Instruments & Apparatus sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2026-05-20 12:00 2026-05-18 Aryeh Jason Director BUY $3.75 665 $2,494 118,118 +0.6%
2026-05-19 12:00 2026-05-15 Hochman David P Director, Officer - See Remarks BUY $3.77 5,000 $18,850 1,059,029 +0.5%
2026-05-19 12:00 2026-05-15 Aryeh Jason Director BUY $3.90 8,971 $34,987 117,453 +8.3%
2026-05-18 12:00 2026-05-14 Fain Eric S Director BUY $4.13 20,000 $82,600 91,709 +27.9%
2026-04-29 21:36 2026-04-27 RTW INVESTMENTS, LP 10% owner SELL $4.13 32 $132 9,556,063 0.0%
2026-03-16 20:54 2026-03-13 Hochman David P Director, Officer - See Remarks BUY $4.29 10,000 $42,900 1,086,467 +0.9%
2025-11-18 01:00 2025-11-14 Hochman David P Director, Officer - See Remarks BUY $4.07 5,000 $20,350 612,822 +0.8%
2025-09-20 01:57 2025-09-19 Aryeh Jason Director BUY $2.45 1,000 $2,450 108,482 +0.9%
2025-08-26 02:01 2025-08-25 Taylor Andrew Lawrence Officer - Chief Financial Officer BUY $2.55 2,000 $5,100 482,788 +0.4%
2025-08-26 02:04 2025-08-25 Sherman Darren Director, Officer - See Remarks BUY $2.62 3,000 $7,860 926,837 +0.3%
2025-08-26 02:04 2025-08-25 Fain Eric S Director BUY $2.61 5,760 $15,034 71,709 +8.7%
2025-08-26 02:03 2025-08-21 Hochman David P Director, Officer - See Remarks BUY $2.49 6,000 $14,940 651,460 +0.9%
2025-08-05 17:46 2025-08-01 PERCEPTIVE ADVISORS LLC 10% owner BUY $2.75 700,000 $1,925,000 5,292,556 +15.2%
2025-08-05 01:16 2025-08-04 Hochman David P Director, Officer - See Remarks BUY $2.75 20,000 $55,000 349,331 +6.1%
2025-06-28 00:10 2025-06-26 Fain Eric S Director SELL $3.05 2,683 $8,183 50,949 -5.0%
2025-05-01 15:18 2025-04-30 RTW INVESTMENTS, LP 10% owner BUY $2.99 49,900 $149,201 8,306,063 +0.6%
2025-04-30 00:16 2025-04-29 RTW INVESTMENTS, LP 10% owner BUY $2.53 50,000 $126,500 8,256,163 +0.6%
2024-12-27 01:46 2024-12-23 Hochman David P Director, Officer - See Remarks BUY $4.66 4,000 $18,640 579,498 +0.7%
2024-12-20 16:30 2024-12-19 Taylor Andrew Lawrence Officer - Chief Financial Officer BUY $4.83 1,000 $4,830 344,960 +0.3%
2024-12-19 16:30 2024-12-18 Hochman David P Director, Officer - See Remarks BUY $4.91 5,000 $24,550 575,498 +0.9%
2024-09-26 15:15 2024-09-24 Hochman David P Director, Officer - See Remarks BUY $4.79 10,000 $47,905 2,000 +100.0%
2024-09-11 02:45 2024-09-09 Sherman Darren Director, Officer - See Remarks SELL $5.39 13,708 $73,946 765,787 -1.8%
2024-09-11 02:43 2024-09-06 Fain Eric S Director SELL $5.48 5,600 $30,666 41,210 -12.0%
2024-09-07 02:31 2024-09-04 Sherman Darren Director, Officer - See Remarks SELL $5.87 20,617 $120,956 779,495 -2.6%
2024-08-16 00:30 2024-08-14 Hochman David P Director, Officer - See Remarks BUY $5.84 2,500 $14,600 567,998 +0.4%
2024-06-26 23:15 2024-06-25 Hochman David P Director, Officer - See Remarks BUY $6.95 1,000 $6,950 333,502 +0.3%
2024-06-03 23:15 2024-05-30 Little William Reed Officer - See Remarks BUY $7.00 4,000 $28,000 307,859 +1.3%
2024-05-22 04:15 2024-05-16 Hochman David P Director, Officer - See Remarks BUY $4.99 5,000 $24,950 332,502 +1.5%
2023-02-02 01:53 2023-01-30 Medtronic plc 10% owner BUY $9.28 6,835 $63,436 4,999,423 +0.1%
SHOW ENTRIES

How to Interpret $OBIO Trades

Not every insider transaction in Orchestra BioMed Holdings, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $OBIO shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for OBIO

Insider activity data for Orchestra BioMed Holdings, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $OBIO, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.